JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 2014-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.jhsph.edu
Sleep Heart Health Study (SHHS) Data Coordinating Center
Completed
- Conditions
- Lung DiseasesSleep Apnea SyndromesCardiovascular DiseasesHeart DiseasesCoronary DiseaseCerebrovascular AccidentHypertensionMyocardial Infarction
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2013-05-21
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 6441
- Registration Number
- NCT00005275
Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3)
Phase 3
Completed
- Conditions
- AsthmaLung Diseases
- Interventions
- First Posted Date
- 1999-10-28
- Last Posted Date
- 2014-04-03
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 1041
- Registration Number
- NCT00000575
Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 64
- Registration Number
- NCT00000142
Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)
Phase 3
Completed
- Conditions
- HIV InfectionsAcquired Immunodeficiency SyndromeCytomegalovirus Retinitis
- Interventions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2015-09-14
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 279
- Registration Number
- NCT00000134
Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)
Phase 2
Completed
- Conditions
- HIV InfectionsCytomegalovirus Retinitis
- Interventions
- Drug: MSL-109Other: Placebo
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 209
- Registration Number
- NCT00000135
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Phase 3
Completed
- Conditions
- Cytomegalovirus RetinitisHIV Infections
- Interventions
- Device: Ganciclovir implant and oral ganciclovir
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 61
- Registration Number
- NCT00000143
- Locations
- 🇺🇸
Department of Ophthalmology, New York Hospital-Cornell Medical Center, New York, New York, United States
🇺🇸Department of Ophthalmology, Mount Sinai School of Medicine, New York, New York, United States
🇺🇸Cullen Eye Institute, Baylor College of Medicine, Houston, Texas, United States
Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
Phase 3
Completed
- Conditions
- HIV InfectionsCytomegalovirus Retinitis
- Interventions
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2015-10-22
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 234
- Registration Number
- NCT00000136
Longitudinal Study of Ocular Complications of AIDS (LSOCA)
Completed
- Conditions
- HIV InfectionsCytomegalovirus RetinitisAcquired Immunodeficiency Syndrome
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2015-06-12
- Lead Sponsor
- Johns Hopkins Bloomberg School of Public Health
- Target Recruit Count
- 2392
- Registration Number
- NCT00000168
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸University of Southern California, Los Angeles, California, United States
🇺🇸Jules Stein Eye Institute, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath